The challenges in obesity research are significant, but the opportunities for innovation are equally profound.
Matt Wilson
Advertisement
Founder and CEO, uMed
Articles by Matt Wilson
Advertisement
Latest Updated Articles
The Future of Obesity Pharmacology: Bridging Evidence Gaps with a New Model for Clinical RegistriesPublished: October 14th 2024 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Tylenol Maker Sued While Kennedy Says No ‘Sufficient’ Evidence for Autism Link
2
Pharmaceutical Executive Daily: Thermo Fisher's $8.8 Billion Acquisition of Clario Holdings
3
Novo Nordisk’s Unsolicited Proposal to Acquire Metsera
4
Dropping US Vaccine Rates Cause Delay in CSL’s Plans to Spin Off Vaccine Division
5
